Wednesday, October 14, 2020

The Efficacy of PSMA Scans and Therapy — Cancer ABCs

The Efficacy of PSMA Scans and Therapy — Cancer ABCs

Wednesday, October 7, 2020

Advanced prostate cancer has an unexpected weakness that can be targeted by drugs: Researchers identified that SUCLA2-deficient prostate cancer cells can be selectively treated with thymoquinone -- ScienceDaily

Advanced prostate cancer has an unexpected weakness that can be targeted by drugs: Researchers identified that SUCLA2-deficient prostate cancer cells can be selectively treated with thymoquinone -- ScienceDaily

Cerenkov luminescence imaging identifies surgical margin status in radical prostatectomy -- ScienceDaily

Cerenkov luminescence imaging identifies surgical margin status in radical prostatectomy -- ScienceDaily

Bone health effects of androgen-deprivation therapy and androgen receptor inhibitors in patients with nonmetastatic castration-resistant prostate cancer | Prostate Cancer and Prostatic Diseases

Bone health effects of androgen-deprivation therapy and androgen receptor inhibitors in patients with nonmetastatic castration-resistant prostate cancer | Prostate Cancer and Prostatic Diseases

ESMO 2020: Latest updates in prostate cancer - YouTube

ESMO 2020: Latest updates in prostate cancer - YouTube

Comparing real world evidence to phase III data on apalutamide for nmCRPC - YouTube

Comparing real world evidence to phase III data on apalutamide for nmCRPC - YouTube

Giri and Gomella on Fostering a New Framework for Genetic Testing Guidelines in Prostate Cancer | OncLive

Giri and Gomella on Fostering a New Framework for Genetic Testing Guidelines in Prostate Cancer | OncLive